Disciplined Investments, LLC Bristol Myers Squibb CO Transaction History

Disciplined Investments, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$63.71 - $70.74 $318 - $353	5 Added 0.54%	931 $59,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $2,037 - $2,310	-31 Reduced 3.24%	926 $64,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $2,944 - $3,486	43 Added 4.7%	957 $68,000
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $4 - $2,919	-38 Reduced 3.99%	914 $65,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $2,759 - $3,039	38 Added 4.16%	952 $73,000
Q1 2022 Apr 22, 2022	BUY	$61.48 - $73.72 $17,890 - $21,452	291 Added 46.71%	914 $67,000
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $16,089 - $18,756	300 Added 92.88%	623 $39,000
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $5,917 - $6,931	100 Added 44.84%	323 $19,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $13,805 - $15,034	223 New	223 $15,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $19,978 - $22,638	-346 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $1,952 - $2,163	-34 Reduced 8.95%	346 $21,000
Q1 2020 May 19, 2020	SELL	$46.4 - $67.43 $1,948 - $2,832	-42 Reduced 9.95%	380 $21,000
Q4 2019 May 19, 2020	BUY	$49.21 - $64.19 $20,766 - $27,088	422 New	422 $27,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.